Literature DB >> 9812522

[Subtype and sequence analysis of the C2-V3 region of gp120 genes among HIV-1 strains in Hubei province].

Y W Li1, Y M Shao, X G Luo.   

Abstract

Twenty DNA fragments of HIV-1 env gene were amplified by PCR from uncultured peripheral blood mononuclear cells (PBMCs) obtained from HIV-1 sero-positive people from Hubei province in the end of 1996. The C2-V3 region (about 450 bp) was sequenced. Sequence analyses showed that all of them were HIV-1 subtypes, B strain, with 1.9% gene divergence innergroup. The 20 subtype B strains, compared with sequences of several reference HIV-1 strains, were closely related to those found in Thailand, Myanma and Yunnan and other provinces in China. The nucleotide sequence divergence between them ranged from 1.9% to 3.2%. These results suggested that recent epidemic of B subtype HIV-1 strains in Hubei province and the responsible virus were very close to those identified in Yunnan province.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9812522

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  3 in total

1.  The HIV-1 epidemic: low- to middle-income countries.

Authors:  Yiming Shao; Carolyn Williamson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

2.  A comprehensive mapping of HIV-1 genotypes in various risk groups and regions across China based on a nationwide molecular epidemiologic survey.

Authors:  Xiang He; Hui Xing; Yuhua Ruan; Kunxue Hong; Chunlin Cheng; Yuanyuan Hu; Ruolei Xin; Jing Wei; Yi Feng; Jenny H Hsi; Yutaka Takebe; Yiming Shao
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

3.  Development of an HIV-1 Subtype Panel in China: Isolation and Characterization of 30 HIV-1 Primary Strains Circulating in China.

Authors:  Jingwan Han; Siyang Liu; Wei Guo; Zuoyi Bao; Xiaolin Wang; Lin Li; Yongjian Liu; Daomin Zhuang; Hanping Li; Lei Jia; Tao Gui; Hongshuai Sui; Tianyi Li; Jingyun Li
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.